Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Though, tabalumab's Phase II clinical studies showed success and proved effective, a recent report has revealed that Eli Lilly and Company's human monoclonal antibody failed in terms of meeting efficacy objectives in a next-stage trial.

Of total three Phase 3 rheumatoid arthritis registration studies, one study of the anti-BAFF monoclonal antibody failed, which the researchers say, was totally unexpected. However, the failure is in no way related to safety concerns.

Therefore, as per the findings, patients currently involved in other studies of tabalumab RA would continue the treatment. Lilly would also be working towards the development of additional treatment options so that patients with autoimmune diseases could have an option.

It has been told that the company would evaluate the candidate in two other studies related to Phase 3 RA registration following the open-label extension study as well as other smaller studies. Since, the company is of the belief that it does not have sufficient data to gain U. S. marketing clearance.

"We remain committed to patients with rheumatoid arthritis and lupus and will move rapidly to evaluate the impact of these data on the overall tabalumab clinical development programme", sources quoted vice president for Lilly autoimmune product development Eiry Roberts as saying.


FrenchTribune Specials

Austin tech leaders unveil ‘RideAustin’ non-profit ride-hailing service

In an announcement made on Monday, tech leaders in Austin unveiled a non-profit car-for-hire service -- called RideAustin -- backed by local donations. The new service is an alternative created by Austin-based engineers to Uber and Lyft ride-hailing services which have been ousted from the city after a contentious regulation scuffle.

The...

Most Popular

Google likely to focus on VR and AI at I/O conference this week

At Google's 2016 I/O developer conference scheduled to...

Twitter may stop counting photos and links towards its 140-character limit

According to a Bloomberg report published on Monday,...

Danish researchers face criticism for publishing OkCupid users’ data

A team of Danish researchers triggered a controversy...

Mark Zuckerberg will meet with top conservative media figureheads this week

In an evident effort to address Facebook's alleged...

Poll

Can Greece Come out of Economic Problems: